Vitridinol, 120 mg 112 pcs

Pharmacotherapeutic group: Intestinal antiseptic and astringent < br> < br> ATX code: A02BX05 < br> < br> Pharmacodynamics:< br> < br> Antiulcer agent with bactericidal activity against Helicobacter pylori. It also has anti-inflammatory and astringent activity. In the acidic environment of the stomach, insoluble bismuth oxychloride and citrate precipitate to form chelated compounds with a protein substrate in the form of a protective film on the surface of ulcers and erosions. By increasing the synthesis of prostaglandin E formation of mucus and secretion of hydrocarbonate stimulates the activity of cytoprotective mechanisms increases resistance of the mucous membrane of the gastrointestinal tract to the effects of pepsin hydrochloric acid enzymes and bile acid salts. Leads to the accumulation of epidermal growth factor in the defect area. Reduces pepsin and pepsinogen activity.< br> < br> < br> Pharmacokinetics:< br> < br> Bismuth tricalium dicitrate is practically not absorbed from the gastrointestinal tract. It is excreted mainly with the feces. A small amount of bismuth entered the plasma is excreted by the kidneys.